COVID-19 in Lymphangioleiomyomatosis,Chest

当前位置： X-MOL 学术 › Chest › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

COVID-19 in Lymphangioleiomyomatosis
Chest ( IF 9.5 ) Pub Date : 2021-12-21 , DOI: 10.1016/j.chest.2021.12.640
Bruno Guedes Baldi ₁ , Elzbieta Radzikowska ₂ , Vincent Cottin ₃ , Daniel F Dilling ₄ , Ali Ataya ₅ , Carlos Roberto Ribeiro Carvalho ₁ , Sergio Harari ₆ , Matthew Koslow ₇ , Jan C Grutters ₈ , Yoshikazu Inoue ₉ , Nishant Gupta ₁₀ , Simon R Johnson ₁₁

Affiliation

Divisão de Pneumologia, Instituto do Coração (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.
National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, University of Lyon, INRAE, Lyon, France.
Division of Pulmonary and Critical Care, Loyola University Chicago, Stritch School of Medicine, Maywood, IL.
Division of Pulmonary, Critical Care and Sleep Medicine, University of Florida, Gainesville, FL.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy; Department of Medicine, Ospedale San Giuseppe MultiMedica IRCCS, Milan, Italy.
ILD Program, Department of Medicine, National Jewish Health, Denver, CO.
ILD Center of Excellence, St. Antonius Hospital Nieuwegein, University Medical Center Utrecht, Utrecht, The Netherlands.
Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.
Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati, Cincinnati, OH.
Translational Medical Sciences, NIHR Biomedical Research Centre and Biodiscovery Institute, University of Nottingham, Nottingham, England; National Centre for Lymphangioleiomyomatosis, Nottingham University Hospitals NHS Trust, Nottingham, England.